지속성 기흉에서 OK-432와 자가혈액을 이용한 흉막 유착술의 효과

Efficacious Pleurodesis with OK-432 Plus Autoblood or OK-432 Against the Pneumothorax with Persistent Air Leak

  • 김형수 (한림대학교 의과대학 흉부외과학교실) ;
  • 최광민 (한림대학교 의과대학 흉부외과학교실)
  • Kim, Hyoung Soo (Department of Thoracic & Cardiovascular Surgery, College of Medicine, Hallym University) ;
  • Choi, Goang Min (Department of Thoracic & Cardiovascular Surgery, College of Medicine, Hallym University)
  • 투고 : 2005.08.31
  • 심사 : 2005.11.28
  • 발행 : 2006.01.30

초록

연구배경 : 지속적인 공기 누출이 있고, 수술적 치료가 가능하지 않았던 기흉 환자들에서 OK-432 또는 OK-432와 자가혈액을 혼합한 흉막 유착제를 이용한 흉막 유착술의 효과를 알아보기 위해 연구를 하였다. 대상 및 방법 : 2004년 3월부터 2005년 7월까지 기흉으로 입원한 환자들 중 흉관을 삽입하고 공기누출이 5일 이상 지속되고, 흉부컴퓨터 촬영 결과 다양한 크기의 기낭과 기종성 변화가 있어, 수술적 치료가 불가능 한 8명의 환자를 대상으로 하였다. 폐의 팽창여부에 따라서 OK-432 또는 OK-432와 자가혈액을 이용한 흉막 유착술을 시행하였다. OK-432의 흉막 유착술의 효과와 부작용을 알아보기 위해 흉막 유착술 후 흉관을 통한 공기누출 시간, 흉막 유착술을 시행한 횟수, 환자의 임상증상, 활력징후 및 일반 혈액검사의 변화와 C-반응단백을 측정하였다. 결 과 : 대상 환자 8명은 모두 남자 였고 평균 나이는 $72.4{\pm}8.5$세였다. 흉막 유착술을 시행한 평균 횟수는 $1.9{\pm}1.1$회였고, 흉막 유착술 후 공기 누출이 멈춘 시간은 평균 $4.6{\pm}4.6$일이었다. 7명의 환자에서 흉막 유착술 후 발생한 부작용은 오한감 7례, 흉통 5례, 두통 3례, 국소부위 열감 2례, 발열 1례 였다. 흉막 유착술 후 백혈구 증가증은 6례에서 관찰 할 수 있었고, 가장 최고치의 평균 백혈구 수는 $14500{\pm}2100$개였고, C-반응단백은 평균 $21.9{\pm}11.4mg/dL$로 증가되는 것을 관찰 할 수 있었다. 결 론 : 공기누출이 지속되고 수술적인 방법으로 치료가 가능하지 않은 기흉 환자에서 OK-432와 자가혈액을 이용한 흉막 유착술은 안전하고 효과적인 것으로 관찰 되어 기존 약제와 더불어 흉막 유착술에 이용하여도 될 것으로 생각된다.

Background : This report reviews our experience with persistent air leaks in the peumothorax that were not considered candidates for surgical treatment in order to evaluate the efficacy and risks of the OK-432 plus autoblood or OK-432 pleurodesis. Material & Methods : From March 2004 to July 2005, 8 consecutive patients who had an air leak in the pneumothorax over 5 days and had been treated with OK-432 plus autoblood or OK-432 pleurodesis. The patients were not considered candidates for surgical treatments because the chest CT findings revealed severe chronic lung disease with multiple bullae and/or bullous changes. A prolonged air leak with/without dead space was treated with either OK-432 plus autoblood or OK-432 pleurodesis. The efficacy and side effects of OK-432 pleurodesis were assessed by determining the duration of the air leak, the number of pleurodesis, the patients' symptoms, measurements of the white blood cell count and the c-reactive protein level. Results : All of eight patients were male and the mean age was $72.4{\pm}8.5$. The mean number of pleurodesis was $1.9{\pm}1.1$ and the mean duration of the air leak was $4.6{\pm}4.6days$ after pleurodesis. Side effects after pleurodesis were encountered in 7 patients, which included a chilling sensation in 7 cases, chest pain in 5 cases, headache in 3 cases, local heat sensation in 2 cases, and fever in 1 case. Leukocytosis was observed in 6 patients, and the mean of WBC count and CRP were $14500{\pm}2100$ and $21.9{\pm}11.4mg/dL$, respectively. Conclusion : Either OK-432 plus autoblood or OK-432 pleurodesis has acceptable side effects, and can be considered a treatment option for persistent air leaks in the pneumothorax that are not candidates for surgical treatment.

키워드

참고문헌

  1. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993;106:689-95
  2. Yoon SM, Shin SJ, Kim YC, Shon JW, Yang SC, Yoon HJ, et al. The effects of autologous blood pleurodesis in the pneumothorax with persistent air leak. Tuberc Respir Dis 2000;49:724-32 https://doi.org/10.4046/trd.2000.49.6.724
  3. Lang-Lazdunski L, Coonar AS. A prospective study of autologous 'blood patch' pleurodesis for persistent air leak after pulmonary resection. Eur J Cardiothorac Surg 2004;26:897-900 https://doi.org/10.1016/j.ejcts.2004.07.034
  4. Kishi K, Homma S, Sakamoto S, Kawabata M, Tsuboi E, Nakata K, et al. Efficious pleurodesis with OK-432 and doxorubicin against malignat pleural effusion. Eur Respir J 2004;24:263-6 https://doi.org/10.1183/09031936.04.00137403
  5. Kim MH, Lee SH, Lee HJ, Kim KT, Lee IS, Kim HM. A case of idiopathic bilateral chylothorax treated by chemical pleurodesis with OK 432. Korean J Thorac Cardiovasc Surg 1995;28:951-3
  6. Chung JH, Park MS, Cheong JH, Kim YS, Chang J, Kim JH, et al. Comparison of OK-432 and doxycycline pleurodesis for malignant pleural effusions caused by lung cancer. Tuberc Respir Dis 2002;52:590-6 https://doi.org/10.4046/trd.2002.52.6.590
  7. Kimura I, Ohnishi T, Yasuhara S, Sugiyama M, Urabe Y. Immunochemotherapy in human lung cancer using the streptococcal agent OK-432. Cancer 1976;37:2201-3 https://doi.org/10.1002/1097-0142(197605)37:5<2201::AID-CNCR2820370507>3.0.CO;2-Q
  8. Yokomise H, Satoh K, Ohno N, Tamura K. Autoblood plus OK 432 pleurodesis with open drainage for persistent air leak after lobectomy. Ann Thorac Surg 1998;65:563-5 https://doi.org/10.1016/S0003-4975(97)01309-X
  9. Song JP, Lee JH, Kim BY, Kang KM. Pleurodesis with autologous blood plus sclerosing agents. Korean J Thorac Cardiovasc Surg 1999;32:92-5
  10. Kim KU, Cha KY, Han SH, Yun YI, Park SW, Kim DJ, et al. A case of acute respiratory distress syndrome after talc pleurodesis. Tuberc Respir Dis 2001;51:265-9 https://doi.org/10.4046/trd.2001.51.3.265